# Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-trial-of-atezolizumab-as-first-line-or-subsequent-therapy-for-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Solange Peters,Scott Gettinger,Melissa L. Johnson,Pasi A. Jänne,Marina Chiara Garassino,Daniel C. Christoph,Chee‐Keong Toh,Naiyer A. Rizvi,Jamie E. Chaft,Enric Carcereny,Jyoti D. Patel,Laura Q.M. Chow,Marianna Koczywas,Cheryl Ho,Martin Früh,Michel M. van den Heuvel,J. Rothenstein,Martin Reck,Luis Paz‐Ares,Frances A. Shepherd,Takayasu Kurata,Zhengrong Li,Jiaheng Qiu,Marcin Kowanetz,Simonetta Mocci,Geetha Shankar,Alan Sandler,Enriqueta Felip |
| Citations | 420 |
| DOI | 10.1200/jco.2016.71.9476 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/20.500.12105/8387 |
| OpenAlex ID | https://openalex.org/W2625684877 |
| PMID | 28609226 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Pasi A. Jänne](https://scholariq.org/researchers/pasi-a-janne/)
- [Frances A. Shepherd](https://scholariq.org/researchers/frances-a-shepherd/)
- [Marina Chiara Garassino](https://scholariq.org/researchers/marina-chiara-garassino/)
- [Jiaheng Qiu](https://scholariq.org/researchers/jiaheng-qiu/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.